These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34983303)

  • 1. DEP domain containing 1B (DEPDC1B) exerts the tumor promoter in hepatocellular carcinoma through activating p53 signaling pathway via kinesin family member 23 (KIF23).
    Shen E; Zhang J; Lu Y
    Bioengineered; 2022 Jan; 13(1):1103-1114. PubMed ID: 34983303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpressed DEPDC1B contributes to the progression of hepatocellular carcinoma by CDK1.
    Dang XW; Pan Q; Lin ZH; Wang HH; Li LH; Li L; Shen DQ; Wang PJ
    Aging (Albany NY); 2021 May; 13(16):20094-20115. PubMed ID: 34032605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [MicroRNA 424-5p promotes the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting Kinesin family member 23].
    Liu XL; Sun CF; Yuan Y; Sheng YJ; Deng CL
    Zhonghua Gan Zang Bing Za Zhi; 2022 Oct; 30(10):1074-1081. PubMed ID: 36727232
    [No Abstract]   [Full Text] [Related]  

  • 4. DEPDC1B is involved in the proliferation, metastasis, cell cycle arrest and apoptosis of colon cancer cells by regulating NUP37.
    Xiong H; Li Y; Liu M
    Mol Med Rep; 2023 Jun; 27(6):. PubMed ID: 37203403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXM1 augments sorafenib resistance and promotes progression of hepatocellular carcinoma by epigenetically activating KIF23 expression.
    Zhu C; Guo H; Ma Z; Shi S; Zhao X; Zhai D; Zhou X; Jiang P; Xu Q; Cai J
    Biochem Biophys Res Commun; 2023 May; 656():1-9. PubMed ID: 36940637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of KIF23 variant 1 expression and relevance as a novel prognostic factor in patients with hepatocellular carcinoma.
    Sun X; Jin Z; Song X; Wang J; Li Y; Qian X; zhang Y; Yin Y
    BMC Cancer; 2015 Dec; 15():961. PubMed ID: 26674738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Therapeutically Targetable TAZ-TEAD2 Pathway Drives the Growth of Hepatocellular Carcinoma via ANLN and KIF23.
    Saito Y; Yin D; Kubota N; Wang X; Filliol A; Remotti H; Nair A; Fazlollahi L; Hoshida Y; Tabas I; Wangensteen KJ; Schwabe RF
    Gastroenterology; 2023 Jun; 164(7):1279-1292. PubMed ID: 36894036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis.
    Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG
    Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DEPDC1 drives hepatocellular carcinoma cell proliferation, invasion and angiogenesis by regulating the CCL20/CCR6 signaling pathway.
    Guo W; Li H; Liu H; Ma X; Yang S; Wang Z
    Oncol Rep; 2019 Sep; 42(3):1075-1089. PubMed ID: 31322256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A putative novel protein, DEPDC1B, is overexpressed in oral cancer patients, and enhanced anchorage-independent growth in oral cancer cells that is mediated by Rac1 and ERK.
    Su YF; Liang CY; Huang CY; Peng CY; Chen CC; Lin MC; Lin RK; Lin WW; Chou MY; Liao PH; Yang JJ
    J Biomed Sci; 2014 Aug; 21(1):67. PubMed ID: 25091805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DEPDC1B promotes colorectal cancer via facilitating cell proliferation and migration while inhibiting apoptosis.
    Han F; Cheng C; Xu Q; Chen J; Yang Z; Liu J
    Cell Cycle; 2023 Jan; 22(1):131-143. PubMed ID: 36016512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinoma.
    Wang SM; Ooi LL; Hui KM
    Clin Cancer Res; 2011 Sep; 17(18):6040-51. PubMed ID: 21825042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53.
    Chen L; Luo L; Chen W; Xu HX; Chen F; Chen LZ; Zeng WT; Chen JS; Huang XH
    Biomed Pharmacother; 2016 Dec; 84():1113-1118. PubMed ID: 27780140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SEPT6 drives hepatocellular carcinoma cell proliferation, migration and invasion via the Hippo/YAP signaling pathway.
    Fan Y; Du Z; Ding Q; Zhang J; Op Den Winkel M; Gerbes AL; Liu M; Steib CJ
    Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33846777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DEP domain containing 1 predicts prognosis of hepatocellular carcinoma patients and regulates tumor proliferation and metastasis.
    Qu D; Cui F; Lu D; Yang Y; Xu Y
    Cancer Sci; 2019 Jan; 110(1):157-165. PubMed ID: 30417471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DEPDC1B is a Novel Direct Target of B-Myb and Contributes to Malignant Progression and Immune Infiltration in Lung Adenocarcinoma.
    Zuo X; Wang D; Tao C; Dou X; Zhao Z; Zhang J; Huang S; Li Y; Zhang X; Bu Y; Wang Y
    Front Biosci (Landmark Ed); 2024 May; 29(6):204. PubMed ID: 38940035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GTSE1 promotes cell migration and invasion by regulating EMT in hepatocellular carcinoma and is associated with poor prognosis.
    Wu X; Wang H; Lian Y; Chen L; Gu L; Wang J; Huang Y; Deng M; Gao Z; Huang Y
    Sci Rep; 2017 Jul; 7(1):5129. PubMed ID: 28698581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
    Wang Y; Wang H; Yan Z; Li G; Hu G; Zhang H; Huang D; Wang Y; Zhang X; Yan Y; Lu Q; Cheng M; Luo S
    Cell Commun Signal; 2020 Jul; 18(1):116. PubMed ID: 32723329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing GTSE-1 expression inhibits proliferation and invasion of hepatocellular carcinoma cells.
    Guo L; Zhang S; Zhang B; Chen W; Li X; Zhang W; Zhou C; Zhang J; Ren N; Ye Q
    Cell Biol Toxicol; 2016 Aug; 32(4):263-74. PubMed ID: 27240802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.